Suraksha Diagnostic Limited (NSE:SURAKSHA)

Market Cap	14.40B -10.2%
Revenue (ttm)	2.94B +21.2%
Net Income	332.95M +7.6%
EPS	6.25 +5.9%
Shares Out	52.08M
PE Ratio	44.23
Forward PE	31.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,204
Average Volume	19,073
Open	276.45
Previous Close	276.45
Day's Range	271.35 - 281.10
52-Week Range	231.00 - 352.50
Beta	n/a
RSI	47.92
Earnings Date	Feb 5, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,300
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SURAKSHA

Financial Performance

In fiscal year 2025, Suraksha Diagnostic's revenue was 2.52 billion, an increase of 15.26% compared to the previous year's 2.19 billion. Earnings were 318.24 million, an increase of 34.70%.